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Population Burden of Long-Term Survivorship After Severe
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Theodore J. Iwashyna, MD, PhD,*† Colin R. Cooke, MD,*‡ Hannah Wunsch, MD,§k and
Jeremy M. Kahn, MD**††
OBJECTIVES: To ascertain the absolute number of
Medicare beneficiaries surviving at least 3 years after
severe sepsis and to estimate their burden of cognitive
dysfunction and disability.
DESIGN: Retrospective cohort analysis of Medicare data.
SETTING: All short-stay inpatient hospitals in the United
States, 1996 to 2008.
PARTICIPANTS: Individuals aged 65 and older.
MEASUREMENTS: Severe sepsis was detected using a
standard administrative definition. Case-fatality, preva-
lence, and incidence rates were calculated.
RESULTS: Six hundred thirty-seven thousand eight hun-
dred sixty-seven Medicare beneficiaries were alive at the
end of 2008 who had survived severe sepsis 3 or more
years earlier. An estimated 476,862 (95% confidence inter-
val (CI) = 455,026–498,698) had functional disability,
with 106,311 (95% CI = 79,692–133,930) survivors hav-
ing moderate to severe cognitive impairment. The annual
number of new 3-year survivors after severe sepsis rose
119% during 1998 to 2008. The increase in survivorship
resulted from more new diagnoses of severe sepsis rather
than a change in case-fatality rates; severe sepsis rates rose
from 13.0 per 1,000 Medicare beneficiary-years to 25.8
(P < .001), whereas 3-year case fatality rates changed
much less, from 73.5% to 71.3% (P < .001) for the same
cohort. Increasing rates of organ dysfunction in hospital-
ized individuals drove the increase in severe sepsis inci-
dence, with an additional small contribution from
population aging.
CONCLUSIONS: Sepsis survivorship, which has substan-
tial long-term morbidity, is a common and rapidly grow-
ing public health problem for older Americans. There has
been little change in long-term case-fatality, despite
changes in practice. Clinicians should anticipate more-fre-
quent sequelae of severe sepsis in their patient populations.
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Severe sepsis occurs when an acute infection leads toorgan dysfunction.1 This syndrome encompasses many
common causes of hospitalization, such as pneumonia
with hypoxemia or urinary tract infection complicated by
acute renal failure. Severe sepsis is also a common cause of
critical illness, as when the organ dysfunctions include
acute respiratory failure or shock. Severe sepsis has been
recognized to have a high acute risk of death.2 More-
recent data demonstrate that survivors of severe sepsis—a
majority of those with the diagnosis—have poor quality of
life,3,4 frequently develop cognitive and functional disabil-
ity,5 and require substantial ongoing acute and long-term
care.6,7 These levels of disability impose a substantial
burden on caregivers.8 Severe sepsis has been termed “a
quintessential disease of aged.”9
Although the effect of severe sepsis on individuals is
understood, little is known about the effect of severe sepsis
on population health—particularly the effect on popula-
tion levels of disability. This stands in marked contrast to
conditions such as cancer and stroke, of which the burdens
of survivorship are considered core components of patient
management and effect on public health.10 Physicians car-
ing for individuals who have survived cancer are aware of
the special physical and emotional sequelae for which they
must maintain a high index of suspicion.11,12 No such
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information exists about whether the population burdens
of severe sepsis survivorship warrant consideration in
discussions of population health, disability, and caregiving
needs.
Therefore, the current study sought to measure the
incidence and prevalence of long-term survivorship after
severe sepsis in Medicare beneficiaries. The primary objec-
tives were to measure the absolute size of the population
Medicare beneficiaries who survive at least 3 years after
severe sepsis and to estimate, based on prior work,5 the
likely numbers with cognitive dysfunction and disability.
Temporal trends in survivorship were also examined, and
several targeted hypotheses regarding potential changes in
sepsis survivorship over time were tested. Specifically, it
was hypothesized that changes in sepsis survivorship might
have resulted from the aging of the population, changing
age-specific rates of hospitalization with infection, chang-
ing rates of acute organ dysfunction in those with infec-
tions, or changes in the case-fatality rate in those with
severe sepsis.
METHODS
Definition of Survivorship
Conceptually, an individual is a “survivor” when the acute
burdens of an illness have passed but the sequelae of that
illness and its treatment may now become important to his
or her health and functioning.13 Operationalizing this is
typically done by defining a time point—necessarily some-
what arbitrary—and examining those who are alive at
least that long after diagnosis.10 The primary outcome of
the current study was survival to 3 years from date of
admission, which is termed 3-year survivorship; this was
based on clinical experience, data on the period of the
greatest risk of mortality after severe sepsis, and compara-
bility with other reports.14,15
Data Source
This retrospective cohort study analyzed all fee-for-service
Medicare beneficiaries aged 65 and older in the 1996 to
2008 Medicare Provider Analysis and Review (MedPAR)
files and the linked Medicare Denominator Files. Medicare
provides insurance for more than 96% of older Ameri-
cans.16 Fewer than 15% of Medicare beneficiaries were in
Medicare managed care programs that did not file claims;
such patients were excluded from these analyses.
A previously validated and widely used claims-based
definition of severe sepsis was relied on.2,6,7,17–21 Only
inpatient hospitalizations in short-stay hospitals (as
opposed to long-term acute care or skilled nursing facili-
ties) were eligible. This definition requires evidence of an
infection and new-onset organ dysfunction during a single
hospitalization, in accordance with the internationally
accepted consensus definition of severe sepsis,1,22 and in
validation studies identifies a similar population to those
identified through chart review.23 This definition has prog-
nostic validity, identifying individuals with substantial
short-2 and long-term mortality,5 high healthcare-related
spending,6,7 and high risk of long-term cognitive and
physical disability.5 This definition is distinct from other
epidemiological approaches to the study of sepsis (rather
than severe sepsis) that primarily use codes for explicit
septicemia, bacteremia, and disseminated fungal infections
rather than for all infections.24 The components of the
severe sepsis definition were used to define hospitalizations
with infection as well as organ dysfunctions. A code for
“severe sepsis” or “septic shock” was considered to be evi-
dence of at least one organ dysfunction, according to the
consensus definition.
As a secondary outcome, spending was defined as the
amount Medicare reimbursed the hospital for the inpatient
stay. To provide a point of comparison for the sepsis find-
ings, the incidence and costs of acute myocardial infarction
(AMI) as a common cause of critical illness of established
importance to population health were also examined.
Hospitalizations with AMI were defined as those with a
primary International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM) diagnostic
code of 410.xx (excluding 410.x2).25,26 Cases with a
length of stay of 1 day were excluded—unless that patient
died, left against medical advice, or was transferred to
another hospital—because such a short length of stay
probably represented exclusion admissions and not true
AMI.27
Disability and Cognitive Impairment Definitions
The burdens of moderate to severe cognitive impairment
and functional disability were estimated using previously
published data for individuals surviving 3 years after
severe sepsis using the same definition of severe sepsis and
drawn from a similar population of Medicare beneficia-
ries.5 In that study, individuals or their proxies were asked
whether, as a result of a health problem, they required
assistance with any of six activities of daily living (ADLs:
walking, dressing, bathing, eating, getting into and out of
bed, and toileting) or five instrumental activities of daily
living (IADLs: preparing a hot meal, shopping for grocer-
ies, making telephone calls, taking medicines, and manag-
ing money). Disability was defined as a limitation in any
ADL or IADL due to a health problem.
Cognitive impairment was defined as poor perfor-
mance on the modified Telephone Interview for Cognitive
Status (m-TICS) or cognitive problems as reported by a
proxy informant similar to a level of impairment associ-
ated with dementia. The m-TICS is 35-point scale that
includes tests of memory, serial seven subtractions, nam-
ing, and orientation, with a score of 0 to 7 defining mod-
erate to severe cognitive impairment.28,29 For individuals
who were unable to be interviewed themselves, the vali-
dated Informant Questionnaire on Cognitive Decline in the
Elderly30 was administered to proxies, and a score of 4.59
to 5.00 indicated moderate to serve cognitive impairment.
Using these definitions in the population of individuals
alive 3 years after severe sepsis in the Health and Retire-
ment Study,5 it was shown that the prevalence of moderate
to severe cognitive impairment was 16.7% (95% confi-
dence interval (CI) = 12.3–21.0%), and 74.8% (95%
CI = 71.3–78.2%) of survivors had at least one limitation
in an ADL or IADL. This disability includes that which
existed before severe sepsis and that associated with severe
sepsis.
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Analysis
The primary outcomes, the incidence and prevalence of
severe sepsis survivorship, were calculated in fee-for-service
Medicare beneficiaries.
To examine temporal trends in the primary outcome,
standard demographic methods were used to measure the
relative contributions when many contributing rates were
each changing. The number of survivors of severe sepsis
was the product of the number of incident cases of severe
sepsis multiplied by 1 minus the case fatality rate. The
number of incident cases of severe sepsis was the product
of the number hospitalizations with infection multiplied by
the organ failure rate per hospitalization with infection.
The number of hospitalizations with infection was the
product of the number of people at risk in each age
group multiplied by the age group–specific infection rate.
A working example of this approach is provided in
Appendix 1.
All rates were calculated on a monthly basis. For
numerators and denominators, individuals were classified
according to their age on the first of each month. All
months in which individuals were in fee-for-service Medi-
care were analyzed.
To test the sensitivity of the conclusions to changes in
specific coding practices for the organ dysfunctions used in
the definition, all of the analyses were replicated sequen-
tially excluding each organ system. Detailed results are in
Appendix 2.
For statistical comparisons, annual differences in inci-
dence rate ratios were tested for using Stata 10.1 (Stata
Corp., College Station, TX). P < .05 was considered statis-
tically significant. Given the large numbers of cases, statis-
tical significance should not be equated with clinical
significance. The University of Michigan institutional
review board approved this work.
RESULTS
In 1996, 34,782,442 Medicare beneficiaries aged 65 and
older were examined for a total of 357,662,059 benefi-
ciary-months. Their median age was 73 (interquartile
range (IQR) 68–79); 59% were female. In 2008,
39,337,348 Medicare beneficiaries were examined for a
total of 350,267,105 beneficiary-months in 2008. Their
median age was 73 (IQR 68–80); 57% were female.
Absolute Number of Survivors and Estimated
Population-Level Burden of Disability
As defined, the incidence of 3-year survivorship in a given
year is the number of individuals still alive exactly 3 years
after being hospitalized with severe sepsis in Medicare.
Using this definition, there were 225,251 new 3-year survi-
vors in Medicare in 2008 (hospitalized for severe sepsis in
2005), up from 102,767 new 3-year survivors in 1999 (hos-
pitalized in 1996), an increase of 119% in a decade (Fig-
ure 1). Repeating the analysis for 5-year survival, the
numbers of new survivors rose from 67,799 in 2001 (hospi-
talized in 1996) to 121,029 in 2008, an increase of 79%.
As defined, the prevalence of 3-year severe sepsis sur-
vivorship in a given year in Medicare is the number of
individuals hospitalized for severe sepsis at least 3 years
earlier and still alive. Using this definition, 637,867 indi-
viduals had survived severe sepsis by at least 3 years as of
the end of 2008 (344,111 who had survived by at least
5 years). This 3-year survivorship number implies that
there were at least 106,311 survivors (95% CI = 79,692–
133,930 survivors) with moderate to severe cognitive
impairment at the end of 2008 in Medicare. In that same
population, there were 476,862 (95% CI = 455,026–
498,698) survivors with functional disability, requiring
assistance with at least one ADL or IADL.
Changes in Number of Cases of Severe Sepsis
There was a significant increase in the number of hospital-
izations for severe sepsis in Medicare (Figure 2). Whereas
387,330 individuals were hospitalized with severe sepsis in
1996, by 2008, 1,015,432 were hospitalized. The rates of
Figure 1. New 3- and 5-year survivors after severe sepsis.
See also Figure 4, which shows the relative contributions of
increasing rates of organ dysfunction per hospitalization with
infection, increasing rates of hospitalization with infection,
population aging, and changes in the 3-year case fatality to
these trends.
Figure 2. Hospitalizations and spending for severe sepsis and
acute myocardial infarction in Medicare. Spending is for the
acute hospitalization only and is not inflation adjusted.
AMI = acute myocardial infarction.
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hospitalization for severe sepsis increased from 13.0 per
1,000 Medicare beneficiary-years in 1996 to 34.8 in 2008
(P < .001). An increase in direct Medicare spending on
hospitalizations for severe sepsis from $6.03 billion to
$15.73 billion accompanied these rising rates of hospital-
ization. To contextualize these numbers for severe sepsis,
they were contrasted with those seen for AMI (Figure 2).
In 1996, there were 325,108 hospitalizations for AMI, an
incidence of 10.91 per 1,000 Medicare beneficiary-years,
at a cost of $3.22 billion. In 2008, there were 227,298
cases of AMI in Medicare in 2008, an incidence of 7.79
per 1,000 Medicare beneficiary-years, at a cost to Medi-
care of $3.16 billion for the acute hospitalizations.
The rising numbers of hospitalization with severe
sepsis resulted primarily from a rise in the rate of organ
dysfunction per hospitalization with infection. The abso-
lute number of hospitalizations with infection increased
from 108 to 121 per 1,000 Medicare beneficiary-years
(P < .001). Rates of organ dysfunction in individuals
hospitalized with infection rose more rapidly, from 12.1%
in 1996 to 28.8% in 2008 (P < .001). Rates of severe
organ dysfunction, defined as the presence of three or
more organ dysfunctions, rose from 0.33% of hospitaliza-
tions with infection in 1996 to 1.64% in 2008, or from
2.7% of hospitalizations with severe sepsis to 5.7% of
such hospitalizations (both P < .001).
Changes in Case Fatality Rate
The potential contribution of changes in case-fatality rate
to the rising severe sepsis survivorship is shown in
Figure 3. There were small improvements in long-term
case-fatality rates after severe sepsis during this period.
Three-year case fatality for individuals who developed
severe sepsis between 1996 and 2005 fell from 73.5% to
71.3% (P < .001). These relatively flat long-term case-
fatality rates contrast with short-term figures. The inpa-
tient case fatality dropped from 28.5% in 1996 to 15.8%
in 2008, with more-modest declines seen in patient-cen-
tered short-term outcomes such as 30-day case fatality
(32.2% to 24.9%) and 90-day case fatality (43.9% to
36.3%) (all P < .001).
Relative Importance of Alternative Mechanisms
The increase in severe sepsis incidence—particularly the
greater incidence of organ dysfunctions in individuals hos-
pitalized with infections—drove the majority of the
increase in the number of survivors (Figure 4). Thus 3-year
survivorship grew 78.2% because of the rising rate of
organ dysfunctions in individuals hospitalized with infec-
tion, whereas the changes in the age distribution, age-
specific infection rate, and 3-year case-fatality rate each
contributed less than 10% to the growth in severe sepsis
survivors.
Sensitivity Analyses
Several sensitivity analyses were conducted for the results—
particularly to changes in coding practice (Appen-
dix 2)—and consistent results were found.
DISCUSSION
Sepsis survivorship is a common and growing feature of
the health care of older Americans. This study establishes
for the first time the pervasiveness of a problem already
proven to be important to individuals and their families;
sepsis survivors are known to be at substantial risk of poor
quality of life, functional disability, and cognitive impair-
ment.3,4,25,31 Hundreds of thousands of individuals with
severe sepsis are surviving years after their illness and face
these challenges. These Medicare data show consistently
rising rates of incident severe sepsis, consistent with past
work in the United States and more-recent work in Eur-
ope.24,32 This study also demonstrates for the first time
that a rising incidence of severe sepsis, rather than changes
in the case-fatality rate after severe sepsis, is driving the
rise in survivorship.
Figure 3. Case-fatality rates after severe sepsis, according to
year in which severe sepsis developed. The case-fatality rate is
the fraction of hospitalizations after which the individuals
died according to the specified time period.
Figure 4. Contributions of the factors to the rising number of
survivors of severe sepsis. This figure shows the relative num-
ber of 3-year survivors who would have been expected had
only each given factor changed. Interpretive example: The
aging of the population alone would have resulted in a 5.7%
increase in the number of 3-year survivors between 1999 and
2008 had other rates remained the same. The figure reveals
that the most important contributor to the growth in the
number of survivors of severe sepsis over this decade was the
increase in the rate of organ dysfunction per patient hospital-
ized with infection, not by better survival among patients with
severe sepsis.
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These findings constitute a set of challenges to physi-
cians and policy-makers. These data suggest a substantial
population burden of older adults with important disabil-
ity after severe sepsis—more than 100,000 with moderate
to severe cognitive impairment and nearly 500,000 with
functional disability. These numbers of disabled survivors
of severe sepsis are of the same order of magnitude as the
numbers of survivors of other recognized public health
problems such as breast cancer survivorship.10 Moreover,
there is evidence that some—perhaps much—of this dis-
ability is attributable to severe sepsis, rather than severe
sepsis being simply a marker for disability. (From individ-
ual-level longitudinal data on severe sepsis survivors, a
hospitalization for severe sepsis was associated with 3.34
times greater odds of moderate to severe cognitive impair-
ment. For those with no disability before severe sepsis,
such a hospitalization was associated with the develop-
ment of 1.57 new limitations in ADLs and IADLs, and for
those with mild to moderate limitations beforehand, sepsis
was associated with the development of 1.50 new limita-
tions.5,19) Such population burden of disability after severe
sepsis argues for an important role of sepsis prevention
and disability mitigation in preserving the independence
of older Americans. Moreover, the downstream costs
of severe sepsis may be substantial—not only in terms of
direct healthcare costs from disability, but also in terms
of caregiver burden, lost productivity, and informal care
needs. Investments by Medicare in programs such as early
mobility33 and delirium prevention34 may offer long-
term returns—in better functioning and lower healthcare
costs—but this needs to be studied.
From a clinical perspective, the importance of increas-
ing rates of organ dysfunction to rising severe sepsis inci-
dence (and hence total numbers of surviving patients)
argues for particular focus on the early inpatient detection
and management of severe sepsis. It has been hypothesized
that there may be a critical window during which effective
treatment of infection (the rates of which are rising only
slightly) may prevent the inflammatory and coagulopathic
cascade of severe sepsis that leads to organ dysfunction.35
If this hypothesis is correct, preventing the conversion of
infection to severe sepsis may have a marked influence on
the population burden of sepsis survivorship. Interventions
such as early antibiotics36 and pneumococcal vaccination
may be effective in this arena—and the cost-effectiveness
analysis should consider their potential to avert the high
societal cost of disability after severe sepsis. It may be
hypothesized that the rising rates of organ dysfunction
result from several causes, including growing use of immu-
nosuppressive medications,37 higher thresholds for hospital
admission in an era of increasing shift toward outpatient
treatment,38 and increased diagnosis of organ injury with
more-sensitive and ubiquitous testing39; establishing the
relative contributions of these different mechanisms may
be an important topic for future research.
There is little evidence of significant declines in case-
fatality rates over longer patient-centered time horizons.
Cohorts that experienced declines in short-term mortality
did not have corresponding declines in long-term mortal-
ity, even though sepsis appears to exert a mortality effect
for at least 5 years after diagnosis.14,15 This unchanged
long-term mortality occurred despite the publication of
several landmark trials during this period, including early
goal-directed therapy for severe sepsis,40 and the introduc-
tion of low tidal volume ventilation for acute lung
injury,41 and an international campaign focused on sepsis-
related quality of care.42,43 A crucial question is whether
these therapies are ineffective at altering the long-term
natural history of severe sepsis, whether the attributable
long-term mortality of severe sepsis is lower than
previously believed,14,15 or whether the implementation
of effective therapies has been too incomplete to affect
population health.44
The results of the current study have several limita-
tions. It focused on severe sepsis within the fee-for-service
Medicare population. Although this is a population in
which previous work demonstrated clear functional and
cognitive disability among survivors,5 it does not include
individuals with severe sepsis not yet eligible for Medicare.
As such, the total population burden of severe sepsis survi-
vorship is probably greater. Second, a widely accepted
operationalization of severe sepsis for national epidemio-
logical work was used; although this definition has been
clinically validated, this is not the same as prospective
assessment of patients, were such a national assessment
feasible. Third, previous estimates of the associations
between severe sepsis and disability showed that there
was less attributable disability after severe sepsis in indi-
viduals who were already severely disabled;5 if there are
more-severely disabled individuals in the U.S. national
population, the estimated burden of severe sepsis survivor-
ship may have been an overestimate. Finally, administra-
tive data were used, and so secular trends in coding
practice for specific organ dysfunctions could have influ-
enced the results; Appendix 2 presents several sensitivity
results. Overall greater attention to secondary diagnoses
might account for some of the overall trend, although
this would more likely represent a failure to code organ
dysfunction in the past than fraudulent coding of organ
dysfunction in the current period.
Severe sepsis has emerged as a dominant cause of seri-
ous illness in Medicare beneficiaries, and survivorship after
severe sepsis is common. There are nearly 500,000
disabled survivors of severe sepsis yet few proven therapies
or specific support programs exist to help or support their
caregivers. Given the enduring cognitive, physical, and
quality-of-life decrements of survivors of severe sepsis,
these individuals and their families may benefit from
efforts to improve and integrate their care—from the pre-
vention of severe sepsis through its acute treatment and
long-term follow-up.
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APPENDICES
Example of Demographic Decomposition
To understand the relative contributions to the changing rates of severe sepsis survivorship, the following approach is
used. First, consider women aged 65 to 69. The following values were calculated for 1996 from the Medicare data:
• POP: the number of Medicare recipients in this group
• HOSP: their age- and sex-specific rate of hospitalization with infection
• DYSFUNC: the aggregate rate of organ dysfunction per hospitalization
• SURVIVE: the aggregate 3-year survival rate for individuals with severe sepsis
The total number of 3-year survivors in this age group of women is mathematically equivalent to
POP 9 HOSP 9 DYSFUNC 9 SURVIVE. Adding subscripts to indicate the reference year, the sex, and the age group,
then the number of 3-year survivors96,W,65–69 = POP96,W,65–69 9 HOSP 96,W,65–69 9 DYSFUNC96 9 SURVIVE96
The total number of 3-year survivors is the sum over both sexes and all age groups of these age- and sex-specific num-
bers of 3-year survivors.
To calculate the effect of population-aging between 1996 and 2005, what would have happened if POP96,W,65–69 were
replaced in the above equations by POP2005,W,65–69 is considered. HOSP 96,W,65–69, DYSFUNC96, and SURVIVE96 are held
constant, but the sum is recalculated. The ratio of this simulated number for 2005 to the actual number of 3-year survi-
vors in 1996 was 1.057. Thus the change in the age distribution accounted for a 5.7% increase in the number of 3-year
survivors over that period, as presented in Figure 4.
A similar logic could be used changing only the year-specific rates for each of the other three terms. This was done to
produce Figure 4.
Sensitivity Analyses to Alternative Severe Sepsis Definitions
In 2002, a new International Classification of Diseases, Ninth Revision, Clinical Modification, code for “severe sepsis”
was introduced. Excluding cases of severe sepsis with this explicit code had little effect on these results, because most such
hospitalizations also had codes for a specific infection and at least one acute organ dysfunction. The analyses were further
replicated with alternative definitions of severe sepsis that excluded each organ dysfunction to ensure that unspecified
changes in coding practice for other conditions did not determine the results. (That is, a definition of severe sepsis was
considered to be an infection plus an organ dysfunction other than, for example, hepatic injury.) Severe sepsis survivorship
rose significantly in all such sensitivity tests, although less so if acute kidney injury was excluded as a severe sepsis-defining
organ dysfunction.
This table is organized as follows. Each column of the table presents the results of the analyses as they occurred under
alternative definitions of severe sepsis. The first column, for reference, provides the results presented in the body of the
manuscript. Important findings are in the italicized rows—they show, for example, a consistent percentage increase in the
number of 3-year survivors across the definitions. The rows entitled “Contributions to 3-year survivorship change” paral-
lel the analysis summarized in Figure 4.
Finally, results for 5-year survival, as is commonly used in oncology, are presented here as well and show a consistent
pattern.
Analytical Variable
Full
Definition
Sensitivity Analyses Excluding Codes for…
Severe Sepsis
and Septic Shock
Cardio-
vascular
Neuro-
logical
Hemato-
logical Hepatic Renal Respiratory
New 3-year survivors, 1999
(got sepsis in 1996), n
102,767 102,767 73,051 87,398 83,898 102,332 82,327 73,260
New 3-year survivors, 2008
(got sepsis in 2005), n
225,251 207,410 164,540 203,084 188,885 223,797 124,560 189,416
Change, 2008 vs 1999, % 219 202 225 232 225 219 151 259
New 5-year survivors, 2001
(got sepsis in 1996), n
67,799 67,799 46,966 58,033 54,794 67,470 55,122 48,832
New 5-year survivors, 2008
(got sepsis in 2003), n
121,029 119,756 85,743 108,803 98,814 12,0262 76,004 97,170
Change, 2008 vs 2001, % 179 177 183 187 180 178 138 199
Incident cases 1996, n 387,330 387,330 289,614 341,586 320,965 384,128 284,144 240,175
Incident cases 2003, n 656,194 645,379 488,511 594,821 544,488 650,126 376,227 467,504
Incident cases 2005, n 791,809 689,826 590,572 722,414 668,707 783,373 413,788 597,456
(Continued)
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Analytical Variable
Full
Definition
Sensitivity Analyses Excluding Codes for…
Severe Sepsis
and Septic Shock
Cardio-
vascular
Neuro-
logical
Hemato-
logical Hepatic Renal Respiratory
Incident cases 2008, n 1,015,432 881,334 751,334 853,751 921,573 1,002,340 425,198 824,543
Change, 2008 vs 1996, % 262 228 259 250 287 261 150 343
Case-fatality rates, %
5-year case-fatality rate,
incident cases from 1996
82.5 82.5 83.8 83.0 82.9 82.4 80.6 79.7
5-year case-fatality rate,
incident cases from 2003
81.6 81.4 82.5 81.7 81.9 81.5 79.8 79.2
3-year case-fatality rate,
incident cases from 1996
73.5 73.5 74.8 74.4 73.9 73.4 71.0 69.5
3-year case-fatality rate,
incident cases from 2005
71.3 69.7 71.9 71.7 71.6 71.2 69.7 68.1
In-hospital case-fatality rate,
incident cases from 1996
28.5 28.5 27.6 30.0 29.7 28.2 25.8 20.2
In-hospital case-fatality rate,
incident cases from 2008
15.8 12.4 13.0 16.0 16.1 15.4 15.7 10.5
Contributions to 3-year survivorship change, %
Population aging 5.7 5.7 5.7 5.7 5.7 5.7 5.7 5.7
Hospitalizations with infection
per person
8.6 8.6 8.6 8.6 8.6 8.6 8.6 8.6
Organ dysfunction per
hospitalization with infection
78.2 55.2 77.7 84.3 81.6 77.8 26.9 116.8
Long-term survival 8.0 14.2 11.3 10.7 8.9 8.0 4.7 4.7
Contributions to 5-year survivorship change, %
Population aging 4.2 4.2 4.2 4.2 4.2 4.2 4.2 4.2
Hospitalizations with infection
per person
8.6 8.6 8.6 8.6 8.6 8.6 8.6 8.6
Organ dysfunction per
hospitalization with infection
49.7 47.3 49.1 53.9 49.9 49.6 17.0 72.0
Long-term survival 5.4 6.1 8.2 7.7 6.3 5.4 4.1 2.2
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